Expression of cyclin A in human leukemia cell line HL-60 following treatment with doxorubicin and etoposide: The potential involvement of cyclin A in apoptosis

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1013-1019

  Zuryn, Agnieszka ^a   Grzanka, Alina ^a   Stepien, Aleksandra ^a   Grzanka, Dariusz ^a   Debski, Robert ^a   Smolinski, Dariusz ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Apoptosis; Cyclin A; Doxorubicin; Etoposide; HL 60

Indexed keywords

CYCLIN A; DOXORUBICIN; ETOPOSIDE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE G2 PHASE; CELL DIVISION; CELL STRAIN HL 60; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMYELOCYTIC LEUKEMIA;

APOPTOSIS; CELL DIVISION; CYCLIN A; DOXORUBICIN; ETOPOSIDE; FLOW CYTOMETRY; G2 PHASE; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE;

EID: 34548573220     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1013     Document Type: Article

References (44)

1. McGowan CH: Regulation of the eukaryotic cell cycle. Prog Cell Cycle Res 5: 1-4, 2003.
2. Garrett MD: Cell cycle control and cancer. Curr Sci 8: 515-522, 2001.
3. Woo RA and Poon RY: Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2: 316-324, 2003.
4. Frouin I, Montecucco A, Biamonti G, Hubscher U, Spadari S and Maga G: Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. EMBO J 21: 2485-2495, 2002. (Pubitemid 34546720)
5. Sobczak-Thepot J, Harper F, Florentin Y, Zindy F, Brechot C and Puvion E: Localization of cyclin A at the sites of cellular DNA replication. Exp Cell Res 206: 43-48, 1993. (Pubitemid 23194677)
6. Tsou MF and Stearns T: Controlling centrosome number: licenses and blocks. Curr Opin Cell Biol 18: 74-78, 2006.
7. D'Assoro AB, Busby R, Suino K, et al: Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint. Oncogene 23: 4068-4075, 2004. (Pubitemid 38747937)
8. Meraldi P, Lukas J, Fry AM, Bartek J and Nigg EA: Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat Cell Biol 1: 88-93, 1999. (Pubitemid 129501949)
9. Lacey KR, Jackson PK and Stearns T: Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 96: 2817-2822, 1999. (Pubitemid 29148801)
10. Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA and Dang CV: Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 91: 6875-6879, 1994. (Pubitemid 24226764)
11. Borgne A and Golsteyn RM: The role of cyclin-dependent kinases in apoptosis. Prog Cell Cycle Res 5: 453-459, 2003.
12. Hiromura K, Pippin JW, Blonski MJ, Roberts JM and Shankland SJ: The subcellular localization of cyclin-dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogene 21: 1750-1758, 2002. (Pubitemid 34259038)
13. Green DR and Reed JC: Mitochondria and apoptosis: Science 281: 1309-1312, 1998.
14. Minn AJ, Swain RE, Ma A and Thompson CB: Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv Immunol 70: 245-279, 1998. (Pubitemid 128678838)
15. Heald R, McLoughlin M and McKeon F: Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74: 463-474, 1993. (Pubitemid 23244612)
16. Ricci MS and Zong WX: Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11: 342-357, 2006.
17. Hengstler JG, Heimerdinger CK, Schiffer IB, et al: Dietary topoisomerase II-poisons: contribution of soy products to infant leukemia. EXCLI J 1: 8-14, 2002.
18. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
19. Evan GI, Wyllie AH, Gilbert CS, et al: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992.
20. Nass SJ and Dickson RB: Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44: 1-22, 1997. (Pubitemid 27179765)
21. Vermeulen K, Berneman ZN and van Bockstaele DR: Cell cycle and apoptosis. Cell Prolif 36: 165-175, 2003. (Pubitemid 36808272)
22. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001. (Pubitemid 32467043)
23. Fukasawa K, Choi T, Kuriyama R, Rulong S and van de Woude GF: Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747, 1996. (Pubitemid 26102826)
24. Wolf D and Rotter V: Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790-794, 1985. (Pubitemid 15142764)
25. Delia D, Aiello A, Soligo D, et al: Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79: 1291-1298, 1992.
26. Walker DH and Maller JL: Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature 354: 314-317, 1991. (Pubitemid 21896885)
27. Harvey KJ, Blomquist JF and Ucker DS: Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2 caspase, and cyclin-dependent kinase activities. Mol Cell Biol 18: 2912-2922, 1998. (Pubitemid 28183460)
28. Bahnassy AA, Zekri AR, El-Houssini S, El-Shehaby AM, Mahmoud MR, Abdallah S and El-Serafi M: Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol 4: 22, 2004.
29. Huuhtanen RL, Blomqvist CP, Bohling TO, et al: Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res 59: 2885-2890, 1999. (Pubitemid 29283127)
30. Kawashima R, Haisa M, Kimura M, et al: Cyclin A correlates with the sensitivity of human cancer cells to cytotoxic effects of 5-FU. Int J Oncol 24: 273-278, 2004.
31. Nakamaki T, Hamano Y, Hisatake J, et al: Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival. Br J Haematol 123: 72-80, 2003. (Pubitemid 37222760)
32. Paterlini P, Suberville AM, Zindy F, et al: Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 53: 235-238, 1993. (Pubitemid 23031829)
33. Shiohara S, Shiozawa T, Miyamoto T, et al: Expression of cyclins, p53 and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease. Virchows Arch 446: 626-633, 2005. (Pubitemid 40922268)
34. Volm M, Koomagi R, Mattern J and Stammler G: Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 75: 1774-1778, 1997. (Pubitemid 27230702)
35. Jin YH, Yoo KJ, Lee YH and Lee SK: Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem 275: 30256-30263, 2000.
36. Meikrantz W and Schlegel R: Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 271: 10205-10209, 1996. (Pubitemid 26131586)
37. Grzanka A, Zuryn A, Styczynski J, Grzanka AA and Wisniewska H: The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line. Neoplasma 52: 489-493, 2005. (Pubitemid 41809407)
38. Jackman M, Kubota Y, Den Elzen N, Hagting A and Pines J: Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell 13: 1030-1045, 2002. (Pubitemid 34250363)
39. Faivre J, Frank-Vaillant M, Poulhe R, et al: Centrosome over-duplication, increased ploidy and transformation in cells expressing endoplasmic reticulum-associated cyclin A2. Oncogene 21: 1493-1500, 2002. (Pubitemid 34226136)
40. Ekberg J, Landberg G, Holm C, Richter J, Wolgemuth DJ and Persson JL: Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoetic and leukemic cells. Oncogene 23: 9082-9089, 2004. (Pubitemid 40013075)
41. Blagosklonny MV: Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs. Oncogene 21: 6249-6254, 2002.
42. 2M checkpoint in myeloid leukaemic cell lines results in loss of cell survival. Br J Haematol 119: 956-964, 2002.
43. 2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death. Clin Cancer Res 6: 3756-3765, 2000.
44. Duraj J, Zazrivcova K, Bodo J, Sulikova M and Sedlak J: Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma 52: 273-279, 2005. (Pubitemid 41076192)